Institute for Molecular Bioscience, University of Queensland, Australia
Correspondence: David A. Hume, Institute for Molecular Bioscience, School of Molecular and Microbial Sciences, Molecular Biosciences Bldg., University of Queensland, Q4072, Australia. E-mail: D.Hume{at}imb.uq.edu.au
|
|
|---|
Key Words: macrophage colony-stimulating factor microarray lipopolysaccharide F4/80 c-fms
|
|
|---|
A major step forward in investigation of the MPS came with the arrival of monoclonal antibody technology. In mouse, rat, and human, hybridomas were made that produced antibodies directed against antigens expressed solely on the surface of presumptive MPS cells. Others have reviewed the biology and usefulness of such markers [2 ]. One such antibody, F4/80, was examined exhaustively [3 ]. The F4/80 antibody recognizes a member of a family of genes also including human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 1 and human CD97 [4 ]. Members of the EGF-TM7 family are characterized by a variable number of NH2-terminal EGF domains and seven transmembrane-spanning hydrophobic regions resembling the G protein-coupled peptide hormone receptor family. The intervening years since description of F4/80 have not revealed a clear function. The knockout mouse has no clear phenotype [5 ], but this could be related to the presence of a related gene with overlapping expression [6 ]. Clues as to function may come from CD97, for which a cellular ligand has been identified (CD55) [5 ].
F4/80 antigen is present on the cell surface of a family of cells that includes all well-defined members of the MPS in the mouse. A unique advantage of the F4/80 antibody was that it bound to an epitope that was resistant to glutaraldehyde fixation and paraffin embedding. For this reason, it was possible to produce high quality images from perfusion-fixed mouse tissues. The full impact of these images was not evident at the time, because they could not be reproduced in print. A large collection of them has been scanned and deposited in a database at www.imb.uq.edu.au/groups/hume/tissuesDB3.html, together with annotation and some comments about possible functions.
There is an inherently circular logic to the use of a single antigenic marker to define a cell type, which in turn defines the specificity of the marker. Nevertheless, the family of F4/80-positive cells had many features in common, regardless of their tissue location. They tend to be highly ramified, and like macrophages in cell culture, they spread on surfaces. The major surface location that is evident in an exhaustive examination of F4/80 location in all tissues is the basement membrane. Every epithelial and endothelial surface in the body has a substantial F4/80-positive cell population spread in the plane of the underlying basement membrane. In stratified epithelia and in the simple epithelia of all secretory ducts, these cells cross the basement membrane and extend processes between the epithelial cells. Associated with epithelia, and indeed in many other locations in the body, the distribution of the F4/80-expressing cells is clearly not random; they occupy a precise anatomical niche. The most striking examples, evident because the pattern is two-dimensional, are the Langerhans cells (LC) of the skin and retinal microglia. In the epidermis of the mouse ear, LC interdigitate among a group of 1213 proliferating, basal keratinocytes at the center of a precise hexagonal array of structural units called squame piles. In the retina, a precise hexagonal array of microglia spreads in the plexiform layers separating the neuronal nuclear layers. A similar order and strict numerical relationship are evident when one views a section that grazes the surface of an epithelial sheet. Examples of each of these locations are included in the database. A precise anatomical location suggests some purpose relating to physiology rather than immunity, a quite distinct view from the concept of the wandering phagocyte. One possible role would be in the phagocytosis and elimination of dying cells, but in sites where physiological apoptosis occurs, it is clear that newly recruited blood monocytes are involved [7 8 9 ]. A second alternative is that tissue macrophages secrete regulators that alter the physiological functions and differentiation of neighboring cells.
The clearest evidence of such roles comes from the study of op/op mice, which have a mutation in the gene encoding the key macrophage growth factor, colony-stimulating factor type 1 (CSF-1) [8 , 9 ] or, more recently, an introduced mutation in the CSF-1 receptor (R; c-fms) locus [10 ]. In fact, mice with these mutations also validate the view that F4/80-positive cells have a common origin. The op/op mice have substantial deficiencies in many F4/80-positive tissue-macrophage populations [8 , 9 ]. The importance of these cells is evident from the male and female infertility and gross sensory neuron dysfunction in op/op mice (see refs. [8 , 9 ]). Interestingly, CSF-1-deficient mice are not completely devoid of F4/80-positive cells in any location, and some populations are unaffected [8 , 9 ]. Furthermore, the number of "CSF-1-dependent" cells, particularly osteoclasts, can increase with age, apparently in part as a result of compensatory actions of other growth factors, vascular endothelial growth factor-A [11 ], and flt3-ligand [12 ].
|
|
|---|
Like F4/80, EGFP is also expressed at very high levels in LC (Fig. 1 ), which are unaffected by the op/op mutation in the CSF-1 gene. LC are regarded as immature precursors of antigen-presenting myeloid DC [18 , 19 ]. The EGFP transgene was also detected uniformly on classical splenic DC, defined by expression of CD11c, and on bone marrow-derived DC produced by cultivation in granulocyte macrophage (GM)-CSF [17 ]. The relationship between macrophages and DC has been a matter of as much debate as the original definition of the MPS. More recently, it has become evident that the poorly endocytic, specialized antigen-presenting cell phenotype of the archetypal DC arises following phagocytic activation of a cell that by most accepted criteria would be called a macrophage [18 , 19 ]. There are relatively few markers that "distinguish" macrophages and DC, and much of the distinction between the two cell types is based on the circular logic inherent in definition by any marker. The EGFP marker expression in MacGreen mice suggests that macrophages and myeloid DC are united by their ability to sustain activity of the c-fms promoter [17 ]. This conclusion is consistent with recent reports on the expression of c-fms on shared macrophage/myeloid DC/osteoclast progenitors in the marrow [20 , 21 ]. In our view, it remains questionable whether there is any real basis for a clear dichotomy between the mononuclear phagocyte cell types or whether there is a continuum of cellular phenotypes that invites classification at the extremes but lacks a clear, distinguishing boundary.
![]() View larger version (138K): [in a new window] |
Figure 1. The green fluorescent protein transgene driven by the c-fms promoter provides a marker for mononuclear phagocytes. The panels show representative tissue sections of tissues rich in mononuclear phagocytes taken from the MacGreen mice in which expression of EGFP is driven by a 6.7-kb c-fms promoter [15
]. LC in the skin (A) and resident tissue macrophages in the liver/Kupffer cells (B), in the spleen (C), and lung (D). RP, Red pulp; WP, white pulp.
|
|
|
|---|
Local proliferation and renewal
van Furth [1
] took the view that tissue macrophage populations do not self-renew and that the most replenishment of these populations arises from monocyte recruitment. A more modern approach to delineating the origins of tissue macrophages has been the use of bone marrow transplantation with genetically marked marrow. One criticism of such studies is that cells undergoing local proliferation may also be affected by radiation required for marrow transplantation so that marrow-derived cells may occupy niches that arise only following such trauma. In any case, a recent study examined reconstitution of tissue macrophage populations following engraftment with lacZ-expressing donor bone marrow cells. Where bone marrow colony-forming cells and splenic macrophages were mainly of donor origin within one month, only 61% of lung and liver macrophages were apparently replaced by donor cells after one year, and microglia were even less likely to be turned over [27
, 28
]. The interpretation favored by the authors is that tissue macrophages turn over slowly. An alternative explanation is that not all tissue macrophages are replaced by blood monocytes in the steady state and that local proliferation makes a significant contribution.
Transdifferentiation
The current opinion of the MPS views this family of cells as being quite distinct from any other cell types in terms of function and origin and as derived from a unique hematopoietic stem cell. This view is being challenged by a deluge of data implicating bone marrow-derived stem cells in production of neurons, hepatocytes, renal epithelial cells, and numerous other cell types [29
30
31
32
33
]. One might accommodate these observations by proposing the existence of a circulating bone marrow-derived mesenchymal stem cell pool, but much of the data suggest they can derive from purified haematopoietic progenitors. There is quite compelling evidence that mature blood monocytes and inflammatory macrophages can transform into vascular elements including endothelial cells, myofibroblasts, and smooth muscle cells [34
35
36
37
38
]. The full extent of their ability to transmogrify is currently unknown, but the possibility that monocytes are actually pluripotent and can differentiate into many other cell types cannot be eliminated based on available information. Gene expression studies (see below) encourage this view. If monocyte-macrophages can transdifferentiate, why not the reverse pathway? In the worm c-elegans, apoptotic cells are engulfed by neighboring cells, which acquire phagocytic activities. Some key genes involved, Ced-6 and Ced-7, have mammalian orthologs that are expressed in circulating phagocytes and are involved in apoptotic cell recognition [39
, 40
]. However, in mice with a deficiency in macrophage production as a result of mutation in the PU.1 gene, neighboring cells can apparently substitute, albeit less effectively, in clearance of dying cells in areas of rapid cell death [41
]. The pathway may be accelerated in malignancy, where many tumor cells express the CSF-1R and can also express other macrophage-associated phenotypic characteristics [42
].
|
|
|---|
(IFN-
)] and LPS [49
]. Even other microbial products that act via other Toll-like receptors, closely related to the LPS-signaling component Tlr4, have additive and distinct effects on macrophage gene expression [50
] and can be affected in quite opposite directions by agonists such as CSF-1 [51
].
![]() View larger version (33K): [in a new window] |
Figure 2. Global changes in gene expression stimulated macrophages. Bone marrow-derived murine macrophages were stimulated with LPS; RNA was extracted and was used to probe a 20,000 element cDNA microarray. The picture shows the distribution of expression levels of the 20,000 genes across five time points after exposure to LPS. Each gene is colored according to the signal intensity measured at time 0. Red indicates the gene was highly expressed at time zero; yellow, moderately expressed; and blue, not expressed at time 0. With time of exposure to LPS, most of the blue elements (initially undetectable) are induced across the time course, and most of the red elements (initially expressed at high levels) are repressed. Very few elements remain static, indicating LPS has a profound effect on the macrophage transcriptome (C. A. Wells, T. Ravasi, D. Hume, et al., unpublished results).
|
|
View this table: [in a new window] |
Table 1. Gene Regulation by LPS in Mouse Macrophages
|
To add one additional layer of complexity, the set of inducible genes observed in mouse macrophages with a defined agonist such as LPS is influenced by genetic background, and cDNA microarrays are starting to give an insight into the full extent of this variation. In a published study, we compared BALB/c and SJL mice, which differ among other things at the Bcg locus, which controls susceptibility to intracellular pathogens [45 ]. Others have also observed global differences in gene regulatory profiles in macrophages from different strains and have linked them to genetic tendencies to generate T helper cell type 1 (Th1) or Th2-dominated, T cell-mediated immune responses. They have even gone so far as to coin the terms M1 and M2 responses for macrophages [62 ]. Our own microarray studies of a wider range of strains suggest that each has its own unique LPS-inducible gene expression profile, including an idiosyncratic set of genes for which there is no detectable expression (unpublished results). This kind of functional polymorphism is actually not so surprising, given the diversity in immunoglobulin, T cell receptor, major histocompatibility complex (MHC), and natural killer (NK) cell receptor genes. A functional innate immune system is required only when a pathogen challenges. By definition, a successful pathogen evades the innate immune system, and mammalian hosts are under strong selection pressure to deal with the full diversity of possible pathogen evasion strategies.
If each mammalian host presents a different challenge to a pathogen because of genetic diversity, each individual macrophage may also be unique. The majority of inducible genes in a macrophage population exposed to LPS or other microbial challenge are expressed only in a subset of cells. Others have favored determinist explanations, including differences in environment such as exposure to different combinations of cytokines and growth factors during macrophage differentiation in the bone marrow and tissue as described above [63 , 64 ]. However, when one starts to examine larger gene sets, the range of combinations of genes starts to challenge credible determinist explanations and definitions of "subpopulations." We have argued that LPS-inducible gene activation (and indeed all transcriptional regulation) is a stochastic process. At the single cell level, individual alleles are expressed or they are not, and gene activation is best described in terms of an increase in frequency or probability of expression [65 ]. We have provided evidence that gene-autonomous, transcriptional probability contributes to the individual diversity of LPS-inducible gene expression in macrophages in a population [44 ]. Where the acquired immune system generates diversity by recombining genomic segments, individual macrophages might present a challenge to a pathogen by expressing a partly random combination of the thousands of inducible host-defense genes.
|
|
|---|
Received March 14, 2002; revised May 7, 2002; accepted May 13, 2002.
|
|
|---|
This article has been cited by other articles:
![]() |
M. T. Silva When two is better than one: macrophages and neutrophils work in concert in innate immunity as complementary and cooperative partners of a myeloid phagocyte system J. Leukoc. Biol., January 1, 2010; 87(1): 93 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Lin, A. P. Castano, B. T. Nowlin, M. L. Lupher Jr., and J. S. Duffield Bone Marrow Ly6Chigh Monocytes Are Selectively Recruited to Injured Kidney and Differentiate into Functionally Distinct Populations J. Immunol., November 15, 2009; 183(10): 6733 - 6743. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hasegawa, H. Liu, B. Ling, J. T. Borda, X. Alvarez, C. Sugimoto, H. Vinet-Oliphant, W.-K. Kim, K. C. Williams, R. M. Ribeiro, et al. The level of monocyte turnover predicts disease progression in the macaque model of AIDS Blood, October 1, 2009; 114(14): 2917 - 2925. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Holub, C.-W. Cheng, S. Mott, P. Wintermeyer, N. van Rooijen, and S. H. Gregory Neutrophils Sequestered in the Liver Suppress the Proinflammatory Response of Kupffer Cells to Systemic Bacterial Infection J. Immunol., September 1, 2009; 183(5): 3309 - 3316. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J Rickard and M. J Young Corticosteroid receptors, macrophages and cardiovascular disease J. Mol. Endocrinol., June 1, 2009; 42(6): 449 - 459. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Ortega, M. J. Pecaut, D. S. Gridley, L. S. Stodieck, V. Ferguson, and S. K. Chapes Shifts in bone marrow cell phenotypes caused by spaceflight J Appl Physiol, February 1, 2009; 106(2): 548 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Wakkach, A. Mansour, R. Dacquin, E. Coste, P. Jurdic, G. F. Carle, and C. Blin-Wakkach Bone marrow microenvironment controls the in vivo differentiation of murine dendritic cells into osteoclasts Blood, December 15, 2008; 112(13): 5074 - 5083. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hume Macrophages as APC and the Dendritic Cell Myth J. Immunol., November 1, 2008; 181(9): 5829 - 5835. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-C. Chiu, V. R. Stolberg, and S. W. Chensue Mononuclear Phagocyte-Derived IL-10 Suppresses the Innate IL-12/IFN-{gamma} Axis in Lung-Challenged Aged Mice J. Immunol., September 1, 2008; 181(5): 3156 - 3166. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, P. C. Hanington, M. Belosevic, and C. J. Secombes Two Macrophage Colony-Stimulating Factor Genes Exist in Fish That Differ in Gene Organization and Are Differentially Expressed J. Immunol., September 1, 2008; 181(5): 3310 - 3322. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Eter, D. R. Engel, L. Meyer, H.-M. Helb, F. Roth, J. Maurer, F. G. Holz, and C. Kurts In Vivo Visualization of Dendritic Cells, Macrophages, and Microglial Cells Responding to Laser-Induced Damage in the Fundus of the Eye Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3649 - 3658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Chang, L.-J. Raggatt, K. A. Alexander, J. S. Kuliwaba, N. L. Fazzalari, K. Schroder, E. R. Maylin, V. M. Ripoll, D. A. Hume, and A. R. Pettit Osteal Tissue Macrophages Are Intercalated throughout Human and Mouse Bone Lining Tissues and Regulate Osteoblast Function In Vitro and In Vivo J. Immunol., July 15, 2008; 181(2): 1232 - 1244. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Craven, J. D. Hall, J. R. Fuller, S. Taft-Benz, and T. H. Kawula Francisella tularensis Invasion of Lung Epithelial Cells Infect. Immun., July 1, 2008; 76(7): 2833 - 2842. [Abstract] [Full Text] [PDF] |
||||
![]() |
M-K Ezzat, C R Hann, S Vuk-Pavlovic, and J S Pulido Immune cells in the human choroid Br J Ophthalmol, July 1, 2008; 92(7): 976 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hume, T. Sasmono, S. R. Himes, S. M. Sharma, A. Bronisz, M. Constantin, M. C. Ostrowski, and I. L. Ross The Ewing Sarcoma Protein (EWS) Binds Directly to the Proximal Elements of the Macrophage-Specific Promoter of the CSF-1 Receptor (csf1r) Gene J. Immunol., May 15, 2008; 180(10): 6733 - 6742. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Ovchinnikov, W. J. M. van Zuylen, C. E. E. DeBats, K. A. Alexander, S. Kellie, and D. A. Hume Expression of Gal4-dependent transgenes in cells of the mononuclear phagocyte system labeled with enhanced cyan fluorescent protein using Csf1r-Gal4VP16/UAS-ECFP double-transgenic mice J. Leukoc. Biol., February 1, 2008; 83(2): 430 - 433. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Lo, P. Gorak-Stolinska, V. Bachy, M. A. Ibrahim, D. M. Kemeny, and J. Maher Modulation of dendritic cell differentiation by colony-stimulating factor-1: role of phosphatidylinositol 3'-kinase and delayed caspase activation J. Leukoc. Biol., December 1, 2007; 82(6): 1446 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Macedo, G. Pinhal-Enfield, V. Alshits, G. Elson, B. N. Cronstein, and S. J. Leibovich Wound Healing Is Impaired in MyD88-Deficient Mice: A Role for MyD88 in the Regulation of Wound Healing by Adenosine A2A Receptors Am. J. Pathol., December 1, 2007; 171(6): 1774 - 1788. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Y. Zhang and R. A. Daynes Macrophages from 11beta-Hydroxysteroid Dehydrogenase Type 1-Deficient Mice Exhibit an Increased Sensitivity to Lipopolysaccharide Stimulation Due to TGF-beta-Mediated Up-Regulation of SHIP1 Expression J. Immunol., November 1, 2007; 179(9): 6325 - 6335. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Whitmore, A. Iparraguirre, L. Kubelka, W. Weninger, T. Hai, and B. R. G. Williams Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3 J. Immunol., September 15, 2007; 179(6): 3622 - 3630. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-H. Pham, S. Langmann, L. Schwarzfischer, C. El Chartouni, M. Lichtinger, M. Klug, S. W. Krause, and M. Rehli CCAAT Enhancer-binding Protein beta Regulates Constitutive Gene Expression during Late Stages of Monocyte to Macrophage Differentiation J. Biol. Chem., July 27, 2007; 282(30): 21924 - 21933. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Sasmono, A. Ehrnsperger, S. L. Cronau, T. Ravasi, R. Kandane, M. J. Hickey, A. D. Cook, S. R. Himes, J. A. Hamilton, and D. A. Hume Mouse neutrophilic granulocytes express mRNA encoding the macrophage colony-stimulating factor receptor (CSF-1R) as well as many other macrophage-specific transcripts and can transdifferentiate into macrophages in vitro in response to CSF-1 J. Leukoc. Biol., July 1, 2007; 82(1): 111 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Ripoll, K. M. Irvine, T. Ravasi, M. J. Sweet, and D. A. Hume Gpnmb Is Induced in Macrophages by IFN-{gamma} and Lipopolysaccharide and Acts as a Feedback Regulator of Proinflammatory Responses J. Immunol., May 15, 2007; 178(10): 6557 - 6566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Wilson, J. M. Napper, J. Denvir, V. E. Sollars, and H. D. Yu Defect in early lung defence against Pseudomonas aeruginosa in DBA/2 mice is associated with acute inflammatory lung injury and reduced bactericidal activity in naive macrophages Microbiology, April 1, 2007; 153(4): 968 - 979. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Yoder, L. E. Mead, D. Prater, T. R. Krier, K. N. Mroueh, F. Li, R. Krasich, C. J. Temm, J. T. Prchal, and D. A. Ingram Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood, March 1, 2007; 109(5): 1801 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lacasa, S. Taleb, M. Keophiphath, A. Miranville, and K. Clement Macrophage-Secreted Factors Impair Human Adipogenesis: Involvement of Proinflammatory State in Preadipocytes Endocrinology, February 1, 2007; 148(2): 868 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ehrchen, L. Steinmuller, K. Barczyk, K. Tenbrock, W. Nacken, M. Eisenacher, U. Nordhues, C. Sorg, C. Sunderkotter, and J. Roth Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes Blood, February 1, 2007; 109(3): 1265 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Rasmussen, J. Cello, H. Gil, C. A. Forestal, M. B. Furie, D. G. Thanassi, and J. L. Benach Mac-1+ Cells Are the Predominant Subset in the Early Hepatic Lesions of Mice Infected with Francisella tularensis Infect. Immun., December 1, 2006; 74(12): 6590 - 6598. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. O. Martinez, S. Gordon, M. Locati, and A. Mantovani Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression J. Immunol., November 15, 2006; 177(10): 7303 - 7311. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dupasquier, P. Stoitzner, H. Wan, D. Cerqueira, A. van Oudenaren, J. S. A. Voerman, K. Denda-Nagai, T. Irimura, G. Raes, N. Romani, et al. The dermal microenvironment induces the expression of the alternative activation marker CD301/mMGL in mononuclear phagocytes, independent of IL-4/IL-13 signaling J. Leukoc. Biol., October 1, 2006; 80(4): 838 - 849. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Laza-Stanca, L. A. Stanciu, S. D. Message, M. R. Edwards, J. E. Gern, and S. L. Johnston Rhinovirus Replication in Human Macrophages Induces NF-{kappa}B-Dependent Tumor Necrosis Factor Alpha Production J. Virol., August 15, 2006; 80(16): 8248 - 8258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nataatmadja, J. West, and M. West Overexpression of Transforming Growth Factor-{beta} Is Associated With Increased Hyaluronan Content and Impairment of Repair in Marfan Syndrome Aortic Aneurysm Circulation, July 4, 2006; 114(1_suppl): I-371 - I-377. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suram, G. D. Brown, M. Ghosh, S. Gordon, R. Loper, P. R. Taylor, S. Akira, S. Uematsu, D. L. Williams, and C. C. Leslie Regulation of Cytosolic Phospholipase A2 Activation and Cyclooxygenase 2 Expression in Macrophages by the beta-Glucan Receptor J. Biol. Chem., March 3, 2006; 281(9): 5506 - 5514. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Alexis, J. C. Lay, K. L. Zeman, M. Geiser, N. Kapp, and W. D. Bennett In Vivo Particle Uptake by Airway Macrophages in Healthy Volunteers Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Fogg, C. Sibon, C. Miled, S. Jung, P. Aucouturier, D. R. Littman, A. Cumano, and F. Geissmann A Clonogenic Bone Marrow Progenitor Specific for Macrophages and Dendritic Cells Science, January 6, 2006; 311(5757): 83 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dauffy, G. Mouchiroud, and R. P. Bourette The interferon-inducible gene, Ifi204, is transcriptionally activated in response to M-CSF, and its expression favors macrophage differentiation in myeloid progenitor cells J. Leukoc. Biol., January 1, 2006; 79(1): 173 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Minge, N. K. Ryan, K. H. V. D. Hoek, R. L. Robker, and R. J. Norman Troglitazone Regulates Peroxisome Proliferator-Activated Receptors and Inducible Nitric Oxide Synthase in Murine Ovarian Macrophages Biol Reprod, January 1, 2006; 74(1): 153 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, A. Manivannan, R. Dawson, I. J. Crane, M. Mack, P. Sharp, and J. Liversidge Differentiation to the CCR2+ Inflammatory Phenotype In Vivo Is a Constitutive, Time-Limited Property of Blood Monocytes and Is Independent of Local Inflammatory Mediators J. Immunol., November 15, 2005; 175(10): 6915 - 6923. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rehli{section}, S. Sulzbacher, S. Pape, T. Ravasi, C. A. Wells, S. Heinz, L. Sollner, C. El Chartouni, S. W. Krause, E. Steingrimsson, et al. Transcription Factor Tfec Contributes to the IL-4-Inducible Expression of a Small Group of Genes in Mouse Macrophages Including the Granulocyte Colony-Stimulating Factor Receptor J. Immunol., June 1, 2005; 174(11): 7111 - 7122. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Modarai, K.G. Burnand, B. Sawyer, and A. Smith Endothelial Progenitor Cells Are Recruited Into Resolving Venous Thrombi Circulation, May 24, 2005; 111(20): 2645 - 2653. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Z. Murray, F. G. Wylie, T. Khromykh, D. A. Hume, and J. L. Stow Syntaxin 6 and Vti1b Form a Novel SNARE Complex, Which Is Up-regulated in Activated Macrophages to Facilitate Exocytosis of Tumor Necrosis Factor-{alpha} J. Biol. Chem., March 18, 2005; 280(11): 10478 - 10483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Jennings, D. J. Linderman, B. Hu, J. Sonstein, and J. L. Curtis Monocytes Recruited to the Lungs of Mice during Immune Inflammation Ingest Apoptotic Cells Poorly Am. J. Respir. Cell Mol. Biol., February 1, 2005; 32(2): 108 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gangnuss, M. L. Sutton-McDowall, S. A. Robertson, and D. T. Armstrong Seminal Plasma Regulates Corpora Lutea Macrophage Populations During Early Pregnancy in Mice Biol Reprod, October 1, 2004; 71(4): 1135 - 1141. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. A. Fortes, I. L. Pecora, P. M. Persechini, S. Hurtado, V. Costa, R. Coutinho-Silva, M. B. M. Braga, F. C. Silva-Filho, R. C. Bisaggio, F. P. de Farias, et al. Modulation of intercellular communication in macrophages: possible interactions between GAP junctions and P2 receptors J. Cell Sci., September 15, 2004; 117(20): 4717 - 4726. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kreiss, S. Toegel, and A. J. Bauer {alpha}2-Adrenergic regulation of NO production alters postoperative intestinal smooth muscle dysfunction in rodents Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G658 - G666. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Hudson Keenihan and S. A. Robertson Diversity in Phenotype and Steroid Hormone Dependence in Dendritic Cellsand Macrophages in the Mouse Uterus Biol Reprod, June 1, 2004; 70(6): 1562 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Goldmann, M. Rohde, G. S. Chhatwal, and E. Medina Role of Macrophages in Host Resistance to Group A Streptococci Infect. Immun., May 1, 2004; 72(5): 2956 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Smith, G. L. Bentz, J. S. Alexander, and A. D. Yurochko Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence J. Virol., May 1, 2004; 78(9): 4444 - 4453. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Girotti, J. H. Evans, D. Burke, and C. C. Leslie Cytosolic Phospholipase A2 Translocates to Forming Phagosomes during Phagocytosis of Zymosan in Macrophages J. Biol. Chem., April 30, 2004; 279(18): 19113 - 19121. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Burnett, E. J. Kershen, J. Zhang, L. Zeng, S. C. Straley, A. M. Kaplan, and D. A. Cohen Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene J. Leukoc. Biol., April 1, 2004; 75(4): 612 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Sunderkotter, T. Nikolic, M. J. Dillon, N. van Rooijen, M. Stehling, D. A. Drevets, and P. J. M. Leenen Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response J. Immunol., April 1, 2004; 172(7): 4410 - 4417. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. T. Lauredo, R. M. Forteza, Y. Botvinnikova, and W. M. Abraham Leukocytic cell sources of airway tissue kallikrein Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L734 - L740. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kruger, D. Benke, F. Eitner, A. Lang, M. Wirtz, E. E. Hamilton-Williams, D. Engel, B. Giese, G. Muller-Newen, J. Floege, et al. Identification and Functional Characterization of Dendritic Cells in the Healthy Murine Kidney and in Experimental Glomerulonephritis J. Am. Soc. Nephrol., March 1, 2004; 15(3): 613 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Teuscher, M. E. Poynter, H. Offner, A. Zamora, T. Watanabe, P. D. Fillmore, J. F. Zachary, and E. P. Blankenhorn Attenuation of Th1 Effector Cell Responses and Susceptibility to Experimental Allergic Encephalomyelitis in Histamine H2 Receptor Knockout Mice Is Due to Dysregulation of Cytokine Production by Antigen-Presenting Cells Am. J. Pathol., March 1, 2004; 164(3): 883 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Frosch, T. Vogl, R. Waldherr, C. Sorg, C. Sunderkotter, and J. Roth Expression of MRP8 and MRP14 by macrophages is a marker for severe forms of glomerulonephritis J. Leukoc. Biol., February 1, 2004; 75(2): 198 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rehli, H.-H. Niller, C. Ammon, S. Langmann, L. Schwarzfischer, R. Andreesen, and S. W. Krause Transcriptional Regulation of CHI3L1, a Marker Gene for Late Stages of Macrophage Differentiation J. Biol. Chem., November 7, 2003; 278(45): 44058 - 44067. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Espinosa-Heidmann, I. J. Suner, E. P. Hernandez, D. Monroy, K. G. Csaky, and S. W. Cousins Macrophage Depletion Diminishes Lesion Size and Severity in Experimental Choroidal Neovascularization Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3586 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wells, T. Ravasi, R. Sultana, K. Yagi, P. Carninci, H. Bono, G. Faulkner, Y. Okazaki, J. Quackenbush, D. A. Hume, et al. Continued Discovery of Transcriptional Units Expressed in Cells of the Mouse Mononuclear Phagocyte Lineage Genome Res., June 1, 2003; 13(6): 1360 - 1365. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||